Pediatric Hematology/Oncology (AREKEN) Osaka Univ Grad School Med

We are treating children with cancer and hematological disorder at Osaka University Hospital, Japan.
Contact us at areken@ped.med.osaka-u.ac.jp

Tuesday, April 25, 2006

Morning Seminar April 25, 2006

Cancer. 2005 Apr 15;103(8):1659-69.

  • Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.

    • Lahaye T, Riehm B, Berger U, Paschka P, Muller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A.

    How about the long-term effect of imatinib on pediatric patients?

    posted by hohtaped @ 8:26 AM